Ovarian Cancer Vaccine for Patients Who Have Progressed During the CAN-003 Study
Clinical trial NCT01617629 · COMPLETED
Trial details
- NCT number
- NCT01617629
- Sponsor
- Prima BioMed Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-01
- Primary completion
- 2014-04-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.